Key Developments For Rodman & Renshaw Capital Group, Inc.
Rodman & Renshaw Capital Group, Inc. (RODM.O) (Consolidated Issue listed on NASDAQ Global Market)
Rodman & Renshaw Capital Group Inc.'s Aceras BioMedical LLC Sells Huxley Pharmaceuticals Inc. To BioMarin Pharmaceutical, Inc.
Rodman & Renshaw Capital Group Inc. announced that its affiliate, Aceras BioMedical LLC (Aceras), has sold Huxley Pharmaceuticals Inc. (Huxley), a portfolio company, to BioMarin Pharmaceutical, Inc. Huxley was established by Aceras in August 2008 with a focus on developing therapeutic products for rare diseases of the nervous system. Under the terms of the agreement, BioMarin paid Huxley stockholders $15.0 million. An additional $7.5 million is payable upon the achievement of regulatory milestones. Further, Huxley stockholders may also receive up to an additional $36 million in milestone payments if certain annual, cumulative sales and U.S. development milestones are met. Aceras owned 95% of Huxley's stock at the time of the transaction. Aceras BioMedical LLC is a joint venture between Aceras Partners LLC and Rodman Principal Investments, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc.
Rodman & Renshaw Capital Group Inc. Announces AEterna Zentaris Inc. To Raise $5.5 Million From Institutional Investors At $1.20 Per Share
Rodman & Renshaw Capital Group Inc. announced that its client AEterna Zentaris Inc. has received commitments to purchase USD5.5 million of units comprised of common shares and common share purchase warrants in a registered direct offering. Rodman & Renshaw, LLC acted as the sole placement agent for the transaction. Under the terms of a Securities Purchase Agreement, the AEterna Zentaris Inc. will sell to such institutional investors an aggregate of approximately 4.58 million common shares of its capital at a price of USD1.20 per share and issue warrants to acquire an aggregate of approximately 1.83 million common shares at an exercise price of USD1.25 per share.
Rodman & Renshaw Capital Group Inc. Announces AUD5.87 Million Private Placement For Citigold Corporation Limited
Rodman & Renshaw Capital Group Inc. announced that its client Citigold Corporation Limited (Citigold) has completed a capital raising of AUD5,872,700 through a private placement to local and international investors. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., and Jesup & Lamont Securities Corp. acted as the placement agents for the transactions with international institutional investors.
Rodman & Renshaw Capital Group Inc. Announces Termination of Cowen Group, Inc. Initiative
Rodman & Renshaw Capital Group Inc. announced that in light of current market conditions its Board of Directors has determined to terminate pursuit of a business combination transaction with Cowen Group, Inc.
Rodman & Renshaw Capital Group Inc. Announces Appointment of Edward Rubin As New Chief Executive Officer
Rodman & Renshaw Capital Group Inc. announced that Edward Rubin, the President and a co founder of Rodman & Renshaw, will succeed Michael Lacovara as Chief Executive Officer.
